Skip to content

Checked

Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies

NCT04772170 on ClinicalTrials.gov

Study listings come from ClinicalTrials.gov, where sponsors register and update their own studies. A listing does not mean a study is safe or effective, and DatenUS does not recommend any study. Talk with your doctor before joining a clinical trial, and use ClinicalTrials.gov for contact details and full eligibility rules.

Status
Recruiting
Phase
Observational
Planned enrollment
1,000
Participants, all sites
U.S. sites
1
In 1 state

Study details

Conditions
Influenza, Respiratory Virus, Coronavirus
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID) (National Institutes of Health)
Ages
18 to 65 years
Sex
All
Healthy volunteers
Accepted
Start
10/23/2023
Primary completion (expected)
06/02/2027
Last updated by sponsor
09/09/2026

Full eligibility rules, contacts and site names: NCT04772170 on ClinicalTrials.gov

Where the study has sites

Cities with at least one listed U.S. site. Some sites may not be enrolling yet.

  • Maryland: Bethesda

Frequently asked questions

What does recruiting mean?
Recruiting means the study is currently enrolling participants. Not yet recruiting means it has been registered but has not started enrolling. Enrolling by invitation means participants are selected by the study team rather than through open enrollment.
How do I join a clinical trial?
Read the full eligibility criteria and contact information on ClinicalTrials.gov, then talk with your doctor about whether a study may be right for you. The study team decides who can enroll.

Source: ClinicalTrials.gov, National Library of Medicine · Last updated 09/09/2026